APA (7th ed.) Citation

Lincoff, A., Kereiakes, D. J., Mascelli, M. A., Deckelbaum, L. I., Barnathan, E. S., Patel, K. K., . . . Topol, E. J. (2001). Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization. Circulation (New York, N.Y.), 104(2), 163-167. https://doi.org/10.1161/01.CIR.104.2.163

Chicago Style (17th ed.) Citation

Lincoff, A.Michael, Dean J. Kereiakes, Mary A. Mascelli, Lawrence I. Deckelbaum, Elliot S. Barnathan, Kamlesh K. Patel, Bart Frederick, Marian T. Nakada, and Eric J. Topol. "Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization." Circulation (New York, N.Y.) 104, no. 2 (2001): 163-167. https://doi.org/10.1161/01.CIR.104.2.163.

MLA (9th ed.) Citation

Lincoff, A.Michael, et al. "Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization." Circulation (New York, N.Y.), vol. 104, no. 2, 2001, pp. 163-167, https://doi.org/10.1161/01.CIR.104.2.163.